BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Drug Development

  bluebird bio Announces Early Data From Phase III Northstar-2 (HGB-207) Study Of LentiGlobin Drug Product At European Hematology Association Annual Meeting

  June 23, 2017

   · 

  7 min read
• Drug Development

  bluebird bio Presents New Data From HGB-205 Study Of LentiGlobin Drug Product In Patients With Transfusion-Dependent ?-Thalassemia (TDT) And Severe Sickle Cell Disease (SCD) At European Hematology Association Annual Meeting

  June 23, 2017

   · 

  10 min read
• Drug Development

  Takeda Presents Data From Phase I/II Studies For NINLARO (Ixazomib) In Newly Diagnosed Multiple Myeloma Patients And In The Maintenance Setting

  June 23, 2017

   · 

  14 min read
• Genetown

  Acceleron Pharma Provides Updated Results From Phase II Studies Of Luspatercept In Beta-Thalassemia At The 22nd Congress Of The European Hematology Association

  June 23, 2017

   · 

  8 min read
• Acceleron Pharma Provides Updated Results From Ongoing Phase II Study Of Luspatercept In Myelodysplastic Syndromes At The 22nd Congress Of The European Hematology Association

  June 23, 2017

   · 

  8 min read
• FDA

  BioDelivery Announces Health Canada Approval Of BELBUCA

  June 23, 2017

   · 

  17 min read
• FDA

  FDA Approves Thermo Fisher Scientific’s First Companion Diagnostic Test to Screen Multiple Non-Small Cell Lung Cancer Therapies

  June 23, 2017

   · 

  3 min read
• Business

  Halyard Health CEO to Retire, New Leader Named

  June 23, 2017

   · 

  3 min read
• Drug Development

  Syros Pharma Presents Data At EHA Supporting Potential Of SY-1425, Its First-In-Class Selective Rara Agonist, In Genomically Defined AML And MDS Patients

  June 23, 2017

   · 

  8 min read
• Genetown

  Catabasis To Present Results From The Movedmd Trial Of Edasalonexent (CAT-1004) At The 2017 PPMD Annual Connect Conference

  June 23, 2017

   · 

  2 min read